Cannabis Drug Market size was valued at USD 23.5 Billion in 2024 and is forecasted to grow at a CAGR of 12.5% from 2026 to 2033, reaching USD 65.4 Billion by 2033.
The cannabis drug market in Malaysia is evolving amidst a rapidly changing global landscape. With increasing interest in medicinal cannabis, the Malaysian government and industries alike are exploring the feasibility of legalizing cannabis for medicinal and potentially recreational use. Despite the current ban on cannabis, the demand for cannabis-related products is expanding, driven by the success of cannabis legalization in other parts of the world. This article explores the cannabis drug market in Malaysia, its current landscape, and the industry requirements for growth.
Currently, cannabis remains illegal in Malaysia for both medicinal and recreational use. The country imposes strict penalties for drug-related offenses, with severe consequences for possession and trafficking. However, the increasing number of successful cannabis treatments in other countries, especially in medical applications, is sparking conversations about the potential for reform. As the global cannabis industry grows, many Malaysian stakeholders are beginning to see the commercial potential of cannabis-based treatments. Experts in healthcare and agriculture are urging the government to reassess its cannabis policies to allow for controlled use in the medicinal sector.
For industries looking to enter the cannabis drug market in Malaysia, there are several factors to consider. First, regulatory frameworks need to be put in place to ensure the legal use of cannabis for medical purposes. This requires developing stringent guidelines for cultivation, processing, and distribution, ensuring that products meet quality standards and are safe for consumer use. Additionally, industries must invest in research to better understand the medicinal properties of cannabis and its potential therapeutic benefits. International partnerships could also be critical for gaining the necessary expertise and technology to build a sustainable cannabis industry in Malaysia.
The cannabis drug market in Malaysia holds immense potential. However, industries must remain patient as the regulatory environment evolves. Stakeholders must also engage with policymakers to highlight the benefits of cannabis in healthcare, focusing on how legalization could create jobs, stimulate economic growth, and improve access to alternative treatment options. Given the global movement toward cannabis reform, Malaysia may eventually open the doors to a legal cannabis market, provided that stringent regulatory measures are in place.
Get an In-Depth Research Analysis of the Malaysia Cannabis Drug Market Size And Forecast [2025-2032]
Greenwich Biosciences
Abbive
Insys Therapeutics
Bausch Health
GW Pharmaceuticals
Unimed Pharmaceuticals
Indevus Pharmaceuticals
Pharmos
By 2030, Malaysia is expected to witness significant momentum in the market research industry, aligning with the global projection of surpassing $120 billion, driven by a compound annual growth rate (CAGR) of over 5.8% from 2023 to 2030. The industry in Malaysia is being reshaped by technological disruptions, particularly through the adoption of machine learning, artificial intelligence, and advanced data analytics. These technologies provide businesses with predictive analysis and real-time consumer insights, enabling smarter and more precise decision-making. As part of the broader Asia-Pacific region, Malaysia is positioned to contribute substantially to the over 35% revenue growth expected from this region. Additionally, the adoption of innovative techniques such as mobile surveys, social listening, and online panels is rapidly gaining ground in Malaysia, emphasizing speed, precision, and customization, and driving a new era of data-driven strategies across industries.
Get Discount On The Purchase of the Malaysia Cannabis Drug Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Malaysia Cannabis Drug Market
Flower
Concentrates
Edibles
Tinctures
Topicals
Smoking
Vaping
Oral Consumption
Topical Application
Sublingual
Recreational Users
Medical Users
High THC
Low THC
THC-Free
Retail Stores
Online Stores
Dispensaries
1. Singapore
Relationship: Strong economic ties; major trading partner.
Highlights: Advanced financial and logistics hub; shares deep cross-border business and travel links with Malaysia.
2. Indonesia
Relationship: Largest ASEAN economy; close cultural and linguistic ties.
Highlights: Major market for Malaysian exports; shared initiatives in palm oil, labor, and regional security.
3. Thailand
Relationship: Land-border neighbor with active cross-border trade.
Highlights: Strong tourism, agricultural, and automotive collaboration.
4. Brunei
Relationship: Close diplomatic and energy-sector ties.
Highlights: Joint ventures in oil & gas; similar Malay cultural heritage.
5. Philippines
Relationship: Regional partner in ASEAN; maritime neighbor.
Highlights: Collaborations in education, labor migration, and disaster relief.
6. Vietnam
Relationship: Growing trade and investment partner.
Highlights: Rising manufacturing hub; strong demand for Malaysian technology and services.
7. Cambodia, Laos, and Myanmar
Relationship: Developing ASEAN members with growing economic ties to Malaysia.
Highlights: Opportunities in construction, retail, and financial services.
For More Information or Query, Visit @ Malaysia Cannabis Drug Market Research Analysis
1. Introduction of the Malaysia Cannabis Drug Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Malaysia Cannabis Drug Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Malaysia Cannabis Drug Market, By Type
6. Malaysia Cannabis Drug Market, By Application
7. Malaysia Cannabis Drug Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia
Vietnam
8. Malaysia Cannabis Drug Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/